Clinical significance of promoter hypermethylation of RASSF1A, RARbeta2, BRCA1 and HOXA5 in breast cancers of Indian patients.

Source:http://linkedlifedata.com/resource/pubmed/id/18538349

Life Sci. 2008 Jun 20 82 25-26 1288-92

Download in:

View as

General Info

PMID
18538349